Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8392)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2019 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tantai XX, Yang LB, Wei ZC, Xiao CL, Chen LR, Wang JH, Liu N. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis. World J Gastroenterol 2019; 25(21): 2683-2698 [PMID: 31210719 DOI: 10.3748/wjg.v25.i21.2683] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i21/2683.htm |
| Number | Citing Articles |
| 1 |
Naina Mohamed Pakkir Maideen. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Medical Journal 2023; 59(2): 115 doi: 10.4068/cmj.2023.59.2.115
|
| 2 |
Akira Sakamaki, Kenya Kamimura, Takeshi Yokoo, Akihiko Osaki, Seiichi Yoshikawa, Yoshihisa Arao, Toru Setsu, Hiroteru Kamimura, Nobuo Waguri, Manabu Takeuchi, Kazuhiro Funakoshi, Shuji Terai. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors. Medicine 2021; 100(32): e26902 doi: 10.1097/MD.0000000000026902
|
| 3 |
Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee. High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study. Alimentary Pharmacology & Therapeutics 2024; 59(8): 973 doi: 10.1111/apt.17909
|
| 4 |
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021; 93(8): 963 doi: 10.26442/00403660.2021.08.200917
|
| 5 |
Pan Zhang, Lizhi Zhou, Li Chen, Zhen Zhang, Rui Han, Gangwen Guo, Haocheng Zhou. Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study. Biomedicines 2022; 10(12): 3040 doi: 10.3390/biomedicines10123040
|
| 6 |
Agastya Patel, Piotr Spychalski, Jarek Kobiela. Letter: mind the gap – search and publication date of systematic reviews and meta‐analysis. Alimentary Pharmacology & Therapeutics 2021; 54(5): 730 doi: 10.1111/apt.16537
|
| 7 |
Yun Su, Yueqiao Chen, Jinghui Zheng, Chun Yao. Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt: a protocol for a systematic review and meta-analysis. BMJ Open 2024; 14(4): e078412 doi: 10.1136/bmjopen-2023-078412
|
| 8 |
Rui Dai, Alan A. Sag, Jonathan G. Martin, Nicholas T. Befera, Waleska M. Pabon-Ramos, Paul V. Suhocki, Tony P. Smith, Charles Y. Kim, Andrew J. Muir, James Ronald. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort. Clinical Imaging 2021; 77: 187 doi: 10.1016/j.clinimag.2021.04.034
|
| 9 |
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 2022; 23(4): 196 doi: 10.1111/1751-2980.13093
|
| 10 |
Rok Orel, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Alexandra Papadopoulou, Carmen Ribes-Koninckx, Mike Thomson, Michael Wilschanski, Nikhil Thapar. Drugs in Focus: Proton Pump Inhibitors. Journal of Pediatric Gastroenterology & Nutrition 2021; 72(5): 645 doi: 10.1097/MPG.0000000000003063
|
| 11 |
K. Toda. Are proton pump inhibitors suitable medicines to prevent upper gastrointestinal events due to non-steroidal anti-inflammatory drugs?. Osteoarthritis and Cartilage 2020; 28(1): e1 doi: 10.1016/j.joca.2019.09.010
|
| 12 |
Carlos Martín de Argila de Prados, Julia Lopez Cardona, Federico Argüelles-Arias. Safe use of proton-pump inhibitors. Revista Española de Enfermedades Digestivas 2023; 115 doi: 10.17235/reed.2023.9834/2023
|
| 13 |
Xiaoli Wu, Daofu Zhang, Yuexiao Yu, Lianqing Lou, Xiaofei Li. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20193890
|
| 14 |
Reidar Fossmark, Tom C. Martinsen, Helge L. Waldum. Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility. International Journal of Molecular Sciences 2019; 20(20): 5203 doi: 10.3390/ijms20205203
|
| 15 |
Haijuan Yao, Hongyu Li, Zhuang Ma, Yanyan Wu, Yufu Tang, Hao Meng, Hao Yu, Chengfei Peng, Yue Teng, Quanyu Zhang, Tianyi Zhu, Haitao Zhao, Guiyang Chu, Zhenhua Tong, Lu Liu, Hui Lu, Xingshun Qi. Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective study. Therapeutic Advances in Gastroenterology 2022; 15: 175628482211043 doi: 10.1177/17562848221104365
|
| 16 |
Maria de Brito Nunes, Matthias Knecht, Reiner Wiest, Jaume Bosch, Annalisa Berzigotti. Predictors and management of post‐banding ulcer bleeding in cirrhosis: A systematic review and meta‐analysis. Liver International 2023; 43(8): 1644 doi: 10.1111/liv.15621
|